Boston Scientific Expects MADIT-CRT Results To Energize CRM Sales
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific is preparing a major sales and marketing effort to support an expanded indication for its cardiac resynchronization therapy devices based on the results of the MADIT-CRT trial